Patents
Patents for C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
12/2004
12/02/2004US20040237837 Benzophenone derivative linked to hydrophylic moiety; concurrently imparts wettability and long term storage stability
12/01/2004EP1481976A1 8-azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient
12/01/2004EP1481970A1 Novel herbicides
12/01/2004EP1481968A2 Cell adhesion-inhibiting anti-inflammatory and immune-suppressive compounds
12/01/2004EP1481966A1 Novel arylamidine derivative or salt thereof
12/01/2004EP1481965A1 Aromatic amino acid derivatives and medicinal compositions
12/01/2004EP1481667A1 NEP inhibitors for the treatment of female sexual dysfunction
12/01/2004EP1481043A2 Hydroxy aromatic mannich base condensation products and the use thereof as soot dispersants in lubricating oil compositions
12/01/2004EP1480961A1 Glutaminyl based dpiv inhibitors
12/01/2004EP1480955A1 O-cyclopropyl-carboxanilides and their use as fungicides
12/01/2004EP1480950A1 Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation, as well as novel processes for preparing atorvastatin hemi-calcium forms i, viii and ix
12/01/2004EP1480628A1 Use of sodium/hydrogen exchange inhibitors for the treatment of thrombotic and inflammatory diseases
12/01/2004EP1351991A4 Ternary biomolecule/polymer/surface-based immobilization systems
12/01/2004EP1246625B1 Uses and compositions of nitrate esters for providing sedation
12/01/2004EP1100778B1 Oxidised sulfurated distamycin derivatives, process for preparing them, and their use as antitumor agents
12/01/2004EP0977745B1 Thioaryl sulfonamide hydroxamic acid compounds
12/01/2004CN1551869A Novel compound
12/01/2004CN1551868A Method for the production of 2-pyrrolidone
12/01/2004CN1550496A Acetylenic alpha-amino acid-based sulfamide hydroxamic acid TACE inhibitors
12/01/2004CN1550491A Novel delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides
12/01/2004CN1177848C Bicyclic heteroaromatic compounds useful as LH agonists
11/2004
11/30/2004US6826033 Beta 3 adrenergic receptor agonists; treatment of pollakiuria, urinary incontinence, obesity or diabetes
11/30/2004US6825360 Bicyclic aromatic compounds
11/30/2004US6825356 Catalysts containing N-pyrrolyl substituted nitrogen donors
11/30/2004US6825354 Osteoporosis; rheumatic diseases
11/30/2004US6825245 Solvent-free; controlling viscosity; material handling
11/30/2004US6825228 To treat infections by gram-positive bacteria, in particular drug- resistant strains
11/30/2004US6825217 Heterocyclic amines such as 4-(3'-thienyl)-alpha, alpha, 1-trimethyl-4-piperidinemethanol and/or prodrugs, used as analgesics for prophylaxis of neuropathic pain
11/30/2004US6825043 Fluorous tagging compounds and methods of increasing the fluorous nature of compounds
11/30/2004CA2322540C Process for preparing a protected 4-aminomethyl-pyrrolidin-3-one
11/25/2004WO2004101523A1 Novel 2-oxo-heterocyclic compounds and the pharmaceutical compositions comprising the same
11/25/2004WO2004101515A1 A process for the preparation of compounds having an ace inhibitory action
11/25/2004WO2004083174A3 Sulfonyl-amidino containing and tetrahydropyrimidino containing compounds as factor xa inhibitors
11/25/2004WO2004060862A3 Compounds having prolyl oligopeptidase inhibitory activity
11/25/2004WO2004007407A3 Fluorous tagging and scavenging reactants and methods of synthesis and use thereof
11/25/2004US20040236118 Efficient and stereoselective production of (2S,4S)-2-[[(3R)-pyrrolidin-3-yl-(R)-hydroxylmethyl]pyrrolidin-4-thiol dihydrochloride useful as intermediate in production of novel carbapenem via a novel crystallizable intermediate by aldol reaction using asymmetric assistant such as amino-alcohol
11/25/2004US20040236117 (ML3000); cyclization of 2,2-dimethyl-3-benzyloyl nitrile by reduction and catalytic hydrogenation; halophenylation with omega-bromo-4-chloroacetophenone; reaction with oxalyl chloride, reduction with hydrazine, and acidification; decreased standing times, improved yields; cyclooxygenase inhibitor
11/25/2004US20040235976 Aliphatic maleimides with substituted nitrogens useful as photoinitiators and polymerization with radiation
11/25/2004US20040235962 Conformationally restricted polyamine analogs as disease therapies
11/25/2004US20040235937 Reacting maleic acid with a substituted-cyclopentylamine derivative; used as separating media for separating optical isomers and geometrical isomers such as by high performance liquid chromatography
11/25/2004US20040235936 Analgesics; anesthetics; antiinflammatory agents; central nervous system duisorders; strokes; antiarthritic agents; inflammatory bowel disorders
11/25/2004US20040235911 hydroxyamidines; antibiotic resistance
11/25/2004US20040235910 Mutilin derivatives and their use as antibacterials
11/25/2004US20040235908 Treating an a-chemokine mediated disease; melanoma, gastric carcinoma, and non-small cell lung cancer, gingivitis, respiratory viruses, herpes viruses, hepatitis viruses, HIV, kaposi's sarcoma associated virus and atherosclerosis
11/25/2004US20040235859 Novel piperazine derivatives
11/25/2004US20040235846 Administering substituted nicotinamides and nicotinamide analogs for therapy of disorder responsive to the induction of apoptosis in an animal; anti-cancer agents
11/25/2004US20040235830 Substituted cyclohexane derivatives and the use thereof in medicaments for treating cardiovascular diseases
11/25/2004US20040235752 3-fluoro-pyrrolidines as antidiabetic agents
11/25/2004US20040235666 Substituted imidates as pesticidal agents
11/25/2004US20040231064 3-Aminophenol derivatives and dyes that contain these compounds while serving to dye keratin fibers
11/25/2004CA2526086A1 Heterocyclic compounds
11/25/2004CA2525442A1 Cyanofluoropyrrolidine derivatives
11/24/2004EP1479669A1 Optically active maleimide derivatives and polymaleimides for use as chiral adsorbent in chromatography
11/24/2004EP1479666A1 Ester compound and medicinal use thereof
11/24/2004EP1479384A1 Fibrosis inhibitor
11/24/2004EP1478623A1 Novel coupling agents, the active intermediates and the conjugates thereof and the use of said conjugates in diagnostic methods
11/24/2004EP1478622A1 Crystalline anhydrous and monohydrate benzoate salts of (2's,3s)-3-hydroxy-n- 2 n-methyl-n-4-(n-propylamino-carbonyl)phenyl]amino-2-phenyl -ethylpyrrolidine
11/24/2004EP1318976B1 Substituted aminopropoxyaryl derivatives useful as agonists for lxr
11/24/2004EP1200406B1 Cyclic amides and imides having selective antagonist activity at alpha-1d adrenergic receptor
11/24/2004EP0929538B1 O?2 -arylated or o?2 -glycosylated 1-substituted diazen-1-ium-1,2-diolates and o?2 -substituted 1- (2-carboxylato)pyrrolidin-1-yl]diazen-1-ium-1,2-diolates
11/24/2004CN1549808A New mandelic acid derivatives and their use as thrombin inhibitors
11/24/2004CN1548428A Carboxylic acid derivatives having fused rings
11/24/2004CN1176906C A process for production of N-methyl pyrrolidone
11/24/2004CN1176902C New esters derived from substituted phenyl-cyclohexyl compounds
11/23/2004US6822057 Olefin polymerization catalysts derived from Group-15 cationic compounds and processes using them
11/23/2004US6821998 Arylamines as inhibitors of chemokine binding to US28
11/23/2004US6821965 Important in disease or medical conditions such as inflammation and immunoregulation
11/23/2004US6821396 Process for fractionating water-containing crude amine mixtures from amine synthesis
11/18/2004WO2004099331A2 Imide-linked maleimide and polymaleimide compounds
11/18/2004WO2004099185A1 2-cyanopyrrolidine derivatives and their use as dpp-iv inhibitors
11/18/2004WO2004099137A1 Aminocyclohexyl ether compounds and uses thereof
11/18/2004WO2004099136A1 Process for producing pyrrolidine derivative
11/18/2004WO2004099134A2 Glutaminyl based dp iv-inhibitors
11/18/2004WO2004099125A1 Method for crystallizing guanidinium salts
11/18/2004WO2004098591A2 Inhibitors of glutaminyl cyclase and their use in the treatment of neurological diseases
11/18/2004WO2004098525A2 Uses of ion channel modulating compounds
11/18/2004WO2004085391B1 Process for the synthesis of amorphous atorvastatin calcium
11/18/2004WO2004085348A3 Production of 5-methyl-n-aryl-2-pyrrolidone and 5-methyl-n-alkyl-2-pyrrolidone
11/18/2004US20040229957 cholesterol ester transfer protein inhibitors, new type of a preventive or therapeutic agent for atherosclerosis or hyperlipidemia
11/18/2004US20040229955 Antibacterial agents
11/18/2004US20040229926 Aliphatic nitrogen - containing 5 - membered ring compound
11/18/2004US20040229909 Antiviral agent
11/18/2004US20040229877 Administering pyrrolotriazine carboxamide and benzamide compounds for therapy of p38 kinase-associated conditions
11/18/2004US20040229874 5HT7 Antagonists and inverse agonists
11/18/2004US20040229864 An aromatic or heteroaromatic ring attached sulfone compound having a nitrogen containing hetero-mono, bi or tricyclic ring useful for treating sleep disorder and depression
11/18/2004US20040229860 For enhancing bone formation; for therapy of diseases or disorders associated with abnormal bone or mineral homeostasis
11/18/2004US20040229858 VLA-4 inhibitor compounds
11/18/2004US20040229848 For therapy of non-insulin dependent diabetes
11/18/2004US20040229819 Hemiasterlin derivatives and uses thereof
11/18/2004CA2526904A1 Blockers of the quorum sensing system of gram-negative bacteria
11/18/2004CA2524718A1 Method for crystallizing guanidinium salts
11/18/2004CA2524034A1 Uses of ion channel modulating compounds
11/17/2004EP1477478A2 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses.
11/17/2004EP1476443A2 Process for preparing indolinone derivatives
11/17/2004EP1476425A2 Heterocyclic arylsulfonamidobenzylic compounds
11/17/2004EP1476423A2 Arylsulfonamidobenzylic compounds
11/17/2004EP1412335A4 ENANTIOSELECTIVE TRANSFORMATION OF $g(a), $g(b)-UNSATURATED ALDEHYDES USING CHIRAL ORGANIC CATALYSTS
11/17/2004EP1263727B1 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses
11/17/2004EP1210333B1 p-Tolyl-heterocycles as herbicides
11/17/2004EP1077931B1 Benzamide derivatives for the treatment of diseases mediated by cytokines